Calidi Biotherapeutics, Inc.
CLDI · CLDWW · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Peoples George: Form 4
Insider disclosure · Filed · Report period 17 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001855485 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CLDI on NYSE, CLDWW on OTC
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 4475 Executive Drive, Suite 200, San Diego, CA, 92121
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- First Light Acquisition Group, Inc. (to 19 Sep 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields